RxSight, Inc. (RXST)
5.05
+0.15
(+3.06%)
USD |
NASDAQ |
Oct 29, 16:00
5.05
0.00 (0.00%)
After-Hours: 16:20
RxSight EPS Diluted (Quarterly) : -0.2916 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2916 |
| March 31, 2026 | -0.3845 |
| December 31, 2025 | -0.2223 |
| September 30, 2025 | -0.2396 |
| June 30, 2025 | -0.2893 |
| March 31, 2025 | -0.2022 |
| December 31, 2024 | -0.1471 |
| September 30, 2024 | -0.1593 |
| June 30, 2024 | -0.1581 |
| March 31, 2024 | -0.247 |
| December 31, 2023 | -0.2552 |
| September 30, 2023 | -0.3481 |
| Date | Value |
|---|---|
| June 30, 2023 | -0.4001 |
| March 31, 2023 | -0.4176 |
| December 31, 2022 | -0.5577 |
| September 30, 2022 | -0.6079 |
| June 30, 2022 | -0.6071 |
| March 31, 2022 | -0.6416 |
| December 31, 2021 | -0.5749 |
| September 30, 2021 | -0.6765 |
| June 30, 2021 | -0.4934 |
| March 31, 2021 | -0.2464 |
| June 30, 2020 | -0.6216 |
| March 31, 2020 | -0.7511 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Precision Optics Corp., Inc. | -0.0095 |
| UFP Technologies, Inc. | 2.677 |
| TransMedics Group, Inc. | 0.4057 |
| Hyperfine, Inc. | -0.0932 |
| Abbott Laboratories | 0.5293 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.10M |
| Revenue (Quarterly) | 33.74M |
| Total Expenses (Quarterly) | 45.84M |
| Enterprise Value | 5.550M |
| Gross Profit Margin (Quarterly) | 76.72% |
| Profit Margin (Quarterly) | -35.85% |
| Earnings Yield | -22.53% |
| Normalized Earnings Yield | -22.53 |